0001562180-20-002902.txt : 20200403 0001562180-20-002902.hdr.sgml : 20200403 20200403175351 ACCESSION NUMBER: 0001562180-20-002902 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200401 FILED AS OF DATE: 20200403 DATE AS OF CHANGE: 20200403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Madaus Martin D CENTRAL INDEX KEY: 0001310268 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38319 FILM NUMBER: 20775091 MAIL ADDRESS: STREET 1: 290 CONCORD ROAD CITY: BILLERICA STATE: MA ZIP: 01821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Quanterix Corp CENTRAL INDEX KEY: 0001503274 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 208957988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 MIDDLESEX TURNPIKE CITY: BILLERICA STATE: MA ZIP: 01821 BUSINESS PHONE: 617-301-9400 MAIL ADDRESS: STREET 1: 900 MIDDLESEX TURNPIKE CITY: BILLERICA STATE: MA ZIP: 01821 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2020-04-01 false 0001503274 Quanterix Corp QTRX 0001310268 Madaus Martin D C/O QUANTERIX CORPORATION, 900 MIDDLESEX TURNPIKE BILLERICA MA 01821 true false false false Common Stock 2020-04-01 4 A false 943.00 19.21 A 10545.00 D Common Stock 2020-04-02 4 M false 4800.00 1.93 A 15345.00 D Common Stock 2020-04-02 4 S false 4800.00 20.00 D 10545.00 D Common Stock 2020-04-02 4 S false 1500.00 20.0146 D 182066.00 I See footnote Common Stock 2020-04-03 4 M false 1600.00 1.93 A 12145.00 D Common Stock 2020-04-03 4 S false 1600.00 20.00 D 10545.00 D Common Stock 2020-04-03 4 S false 2701.00 20.4336 D 179365.00 I See footnote Common Stock 2020-04-03 4 S false 599.00 21.151 D 178766.00 I See footnote Stock Option (Right to Buy) 1.93 2020-04-02 4 M false 4800.00 0.00 D 2021-01-05 Common Stock 4800.00 37707.00 D Stock Option (Right to Buy) 1.93 2020-04-03 4 M false 1600.00 0.00 D 2021-01-05 Common Stock 1600.00 36107.00 D Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the first quarter of 2020, pursuant to an election made in December 2019. Closing price of the Company's common stock on the Nasdaq Global Market on April 1, 2020. Includes 2,270 Restricted Stock Units. All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. This transaction was executed in multiple trades at prices ranging from $20.00 to $20.045. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control. This transaction was executed in multiple trades at prices ranging from $20.03 to $21.01. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $21.05 to $21.28. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. All options are vested and exercisable. /s/ Brian Keane, Attorney-in-fact 2020-04-03